GUTS did a 1-for-12 reverse split on Oct 5, 2026. Fund positions use its last close before the split, $0.4070 on Oct 2, 2026, until the new shares are matched.

GUTS

FRACTYL HEALTH INC

GUTS·35168W103·US·Common Stock·Healthcare - Biotechnology-13D/G

GUTS (FRACTYL HEALTH INC) is held by 40 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($4.8M), BANK OF AMERICA CORP /DE/ ($4.8M), MAVERICK CAPITAL LTD ($3.2M). Net institutional sentiment: Mixed.

40
Holders
(1 Elite)
$23.5M
Total Value
50% (34)
Consensus
17 buying - 17 selling
13F: Insider & Congress: Updated regularly
GUTS

Smart Money Verdict

View all
Loading verdict
Held by 40 funds
1 elite

Who's Trading

Source dates: Price Oct 15, 2026 · Insiders Sep 16, 2026 · Activists May 15, 2026 · Congress none

InsiderBWBRADLEY WILLIAMBuy $40KSep 14, 2026
InsiderRARoyan AjayBuy $20KJun 12, 2026
InsiderBWBRADLEY WILLIAMBuy $50KJun 10, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
6.1M(+10.2%)$4.8M0.0%-24.11%
30
Increased
6M(+4727.7%)$4.8M0.0%-50.57%
43
Unchanged
4M$3.2M0.0%-94.50%
0
Decreased
1.8M(-15.8%)$1.4M0.0%-80.80%
0
Decreased
1.8M(-20.4%)$1.4M0.0%-76.47%
0
Increased
1.7M(+4260.8%)$1.4M0.0%-50.80%
41
Decreased
1.6M(-2.6%)$1.3M0.0%-70.17%
0
Decreased
1.3M(-8.3%)$1M0.0%-80.20%
0
Increased
1.1M(+33.8%)$853,7260.0%-76.19%
32
Increased
916,321(+294.3%)$719,2660.0%-64.93%
40
Increased
722,132(+19.1%)$573,3730.0%-26.75%
29
Increased
516,000(+11.0%)$409,9100.0%-81.36%
18
Decreased
426,504(-14.0%)$338,8150.0%-80.34%
0
Increased
261,907(+21.3%)$208,0590.0%-79.89%
19
Decreased
224,537(-53.2%)$178,3720.0%-81.83%
0
Unchanged
200,000$158,8800.0%-72.87%
0
Increased
175,864(+157.0%)$139,7060.0%-69.20%
24
Unchanged
168,500$133,8560.0%-81.33%
0
Increased
122,200(+247.2%)$97,0760.0%-63.72%
35
Increased
106,216(+5.4%)$83,9090.0%-69.04%
23

Showing 1-20 of 47

1 / 3
GUTSGUTSFRACTYL HEALTH INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used